Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production

Human natural killer (NK) cells and T lymphocytes can bind to and inhibit the growth of the yeast-like organism Cryptococcus neoformans. Binding of target cells to NK or T cells also has the potential to modulate cytokine production by the effector cells. In this study, we assessed the ability of C. neoformans to modulate NK cell production, or in some cases T-cell production, of granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumor necrosis factor alpha (TNF-alpha). We found that freshly isolated human NK cells from most individuals make GM-CSF and TNF-alpha constitutively when cultured in vitro. The addition of C. neoformans to T-cell fractions which do not make GM-CSF constitutively did not affect GM-CSF production, but the addition of C. neoformans to NK cell fractions significantly reduced the amounts of GM-CSF produced in most NK cell samples. The reduction in the amount of GM-CSF in C. neoformans-NK cell cocultures could not be attributed to loss of lymphocyte viability or to C. neoformans adsorbing or degrading the cytokine and was dependent on direct contact between the NK cells and cryptococcal cells. GM-CSF was not the only cytokine to be down-regulated. TNF-alpha production was also diminished when NK cells were incubated with C. neoformans. The regulation of both cytokines was at the transcriptional level because GM-CSF and TNF-alpha mRNA levels were lower in NK cell samples incubated with C. neoformans than in NK cell samples incubated without C. neoformans. Diminished production of constitutively produced cytokines resulting from the interaction of NK cells with cryptococcal cells has the potential to affect phagocytic cells in the immediate regional environment and to damp the immune response.

[1]  M. Burdick,et al.  Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. , 1996, Journal of immunology.

[2]  S. Levitz,et al.  gamma Interferon gene expression and release in human lymphocytes directly activated by Cryptococcus neoformans and Candida albicans , 1996, Infection and immunity.

[3]  J. Murphy,et al.  Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice , 1995, Infection and immunity.

[4]  G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[5]  A. Bajpai,et al.  Target cell-induced inactivation of cytolytic lymphocytes. Role and regulation of CD45 and calyculin A-inhibited phosphatase in response to interleukin-2. , 1994, The Journal of biological chemistry.

[6]  Z. Brahmi,et al.  Target cell-directed rapid degradation of TNF-α messenger RNA in human cytotoxic T cells , 1994 .

[7]  J. Curtis,et al.  Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. , 1994, Journal of immunology.

[8]  S. Levitz,et al.  Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans , 1994, Infection and immunity.

[9]  P. Scott,et al.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice , 1993, The Journal of experimental medicine.

[10]  G. Trinchieri,et al.  Interleukin-12 and its role in the generation of TH1 cells. , 1993, Immunology today.

[11]  S. Wong,et al.  Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. , 1993, The Journal of clinical investigation.

[12]  S. Levitz,et al.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. , 1993, The Journal of clinical investigation.

[13]  G. Bancroft,et al.  Cytokine enhancement of complement‐dependent phagocytosis by macrophages: synergy of tumor necrosis factor‐α and granulocyte‐macrophage colony‐stimulating factor for phagocytosis of Cryptococcus neoformans , 1992, European journal of immunology.

[14]  S. Levitz Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans , 1991, Infection and immunity.

[15]  D. Blanchard,et al.  Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. , 1991, Blood.

[16]  K. Mühlegger,et al.  Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2'-3'-dideoxy-uridinetriphosphate-labeled oligonucleotide probes. , 1991, Human immunology.

[17]  J. Murphy,et al.  Murine natural killer cells are fungicidal to Cryptococcus neoformans , 1991, Infection and immunity.

[18]  J. Murphy,et al.  Responses of murine natural killer cells to binding of the fungal target Cryptococcus neoformans , 1991, Infection and immunity.

[19]  J. Murphy,et al.  Binding interactions of murine natural killer cells with the fungal target Cryptococcus neoformans , 1991, Infection and immunity.

[20]  J. Gasson Molecular physiology of granulocyte-macrophage colony-stimulating factor. , 1991, Blood.

[21]  J. Murphy,et al.  Mechanisms of natural resistance to human pathogenic fungi. , 1991, Annual review of microbiology.

[22]  Craig W. Reynolds,et al.  Cytoplasmic Components of Natural Killer Cells Limit the Growth of Cryptococcus neoformans , 1990, Journal of leukocyte biology.

[23]  S. Banks,et al.  Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans. , 1990, The Journal of infectious diseases.

[24]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[25]  J. Murphy,et al.  Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans , 1989, Infection and immunity.

[26]  G. Trinchieri,et al.  Production of hematopoietic colony-stimulating factors by human natural killer cells , 1989, The Journal of experimental medicine.

[27]  S. Roncella,et al.  Production of colony-stimulating activity by human natural killer cells: analysis of the conditions that influence the release and detection of colony-stimulating activity. , 1989, Blood.

[28]  H. Friedman,et al.  Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. , 1988, Journal of immunology.

[29]  G. Trinchieri,et al.  Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells , 1988, The Journal of experimental medicine.

[30]  G. Toews,et al.  Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. , 1987, The American journal of pathology.

[31]  J. Murphy,et al.  Natural cellular resistance of beige mice against Cryptococcus neoformans. , 1986, Journal of immunology.

[32]  R. Schmickel,et al.  The human 18S ribosomal RNA gene: evolution and stability. , 1986, American journal of human genetics.

[33]  J. Murphy,et al.  Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells , 1986, Infection and immunity.

[34]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[35]  K. Arai,et al.  Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Bohlen,et al.  Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D J Jolly,et al.  Isolation and characterization of a full-length expressible cDNA for human hypoxanthine phosphoribosyl transferase. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Murphy,et al.  In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. , 1982, Journal of immunology.

[39]  J. Murphy,et al.  Immunological Unresponsiveness Induced by Cryptococcal Capsular Polysaccharide Assayed by the Hemolytic Plaque Technique , 1972, Infection and immunity.